Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $73.00 billion. The enterprise value is $85.08 billion.
| Market Cap | 73.00B |
| Enterprise Value | 85.08B |
Important Dates
The last earnings date was Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.45 billion shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -1.35% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 93.59% |
| Float | 1.44B |
Valuation Ratios
The trailing PE ratio is 20.41 and the forward PE ratio is 15.27. BSX's PEG ratio is 1.20.
| PE Ratio | 20.41 |
| Forward PE | 15.27 |
| PS Ratio | 3.48 |
| Forward PS | 3.38 |
| PB Ratio | 2.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.14 |
| P/OCF Ratio | 16.12 |
| PEG Ratio | 1.20 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.90, with an EV/FCF ratio of 23.47.
| EV / Earnings | 23.16 |
| EV / Sales | 4.05 |
| EV / EBITDA | 14.90 |
| EV / EBIT | 19.80 |
| EV / FCF | 23.47 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.24 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 3.48 |
| Interest Coverage | 11.84 |
Financial Efficiency
Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 11.20%.
| Return on Equity (ROE) | 15.34% |
| Return on Assets (ROA) | 6.19% |
| Return on Invested Capital (ROIC) | 11.20% |
| Return on Capital Employed (ROCE) | 11.08% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | $355,864 |
| Profits Per Employee | $62,271 |
| Employee Count | 59,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, BSX has paid $193.00 million in taxes.
| Income Tax | 193.00M |
| Effective Tax Rate | 5.00% |
Stock Price Statistics
The stock price has decreased by -52.50% in the last 52 weeks. The beta is 0.57, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -52.50% |
| 50-Day Moving Average | 46.42 |
| 200-Day Moving Average | 69.43 |
| Relative Strength Index (RSI) | 56.86 |
| Average Volume (20 Days) | 20,762,031 |
Short Selling Information
The latest short interest is 22.28 million, so 1.54% of the outstanding shares have been sold short.
| Short Interest | 22.28M |
| Short Previous Month | 27.94M |
| Short % of Shares Out | 1.54% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 1.08 |
Income Statement
In the last 12 months, BSX had revenue of $21.00 billion and earned $3.67 billion in profits. Earnings per share was $2.47.
| Revenue | 21.00B |
| Gross Profit | 14.53B |
| Operating Income | 4.30B |
| Pretax Income | 3.86B |
| Net Income | 3.67B |
| EBITDA | 5.71B |
| EBIT | 4.30B |
| Earnings Per Share (EPS) | $2.47 |
Balance Sheet
The company has $539.00 million in cash and $12.62 billion in debt, with a net cash position of -$12.09 billion or -$8.34 per share.
| Cash & Cash Equivalents | 539.00M |
| Total Debt | 12.62B |
| Net Cash | -12.09B |
| Net Cash Per Share | -$8.34 |
| Equity (Book Value) | 25.17B |
| Book Value Per Share | 17.23 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was $4.53 billion and capital expenditures -$904.00 million, giving a free cash flow of $3.63 billion.
| Operating Cash Flow | 4.53B |
| Capital Expenditures | -904.00M |
| Depreciation & Amortization | 1.41B |
| Net Borrowing | 978.00M |
| Free Cash Flow | 3.63B |
| FCF Per Share | $2.50 |
Margins
Gross margin is 69.19%, with operating and profit margins of 20.47% and 17.50%.
| Gross Margin | 69.19% |
| Operating Margin | 20.47% |
| Pretax Margin | 18.39% |
| Profit Margin | 17.50% |
| EBITDA Margin | 27.20% |
| EBIT Margin | 20.47% |
| FCF Margin | 17.27% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 5.03% |
| FCF Yield | 4.97% |
Analyst Forecast
The average price target for BSX is $62.69, which is 24.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.69 |
| Price Target Difference | 24.46% |
| Analyst Consensus | Buy |
| Analyst Count | 31 |
| Revenue Growth Forecast (3Y) | 5.95% |
| EPS Growth Forecast (3Y) | 7.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.8 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 7 |